Company Filing History:
Years Active: 2008
Title: Inventor Spotlight: Jérôme Duranton
Introduction
Jérôme Duranton is an innovative inventor based in Strasbourg, France. With a focus on neuropharmacology, he has made significant contributions to the development of compounds that target specific diseases affecting the nervous system. His work has garnered attention in the pharmaceutical industry, particularly through his patent related to PDE2 inhibitors.
Latest Patents
Duranton holds a patent for "Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof." This invention relates to a range of compounds that exhibit PDE2 inhibitory activities. These compounds are particularly valuable for treating various diseases of the central or peripheral nervous system. The patent also discusses pharmaceutical compositions containing these compounds and the methods for preparing them.
Career Highlights
Currently, Duranton works at Via Pharmaceuticals, Inc., a company that focuses on advancing pharmacological research and developing effective treatments for complex diseases. His patent highlights his commitment to enhancing therapeutic options for patients suffering from neurological conditions.
Collaborations
In his pursuit of innovation, Duranton collaborates with esteemed colleagues such as Mustapha Abarghaz and Stefano Biondi. These collaborations reflect a strong partnership that fosters creativity and promotes breakthroughs in pharmaceutical development.
Conclusion
Jérôme Duranton's contributions to science, particularly within the realm of neuropharmacology, exemplify the significance of innovation in addressing critical health challenges. As an inventor, his work not only advances research but also holds potential therapeutic benefits for individuals battling neurological diseases.